Introduction
Lentiviral vectors are an important tool for the genetic modification of human cells for research or therapeutic purposes. They can be pseudotyped with glycoproteins from other enveloped viruses, in some cases after the truncation of cytoplasmic tails that interfere with particle incorporation. 1, 2 The glycoprotein G of vesicular stomatitis virus (VSV) has widely been used for pseudotyping. 3 Recently, we achieved pseudotyping of lentiviral vectors with the envelope proteins of a vaccine strain of measles virus (MV). 4 Precise truncations of the cytoplasmic tails of the MV attachment protein hemagglutinin (H) and the fusion protein (F) were crucial for efficient pseudotyping. These data have been confirmed by Frecha et al. 5 Moreover, we showed that such MV Vac -HIV vectors allow the retargeting of cell entry to CD20-positive lymphocytes after de-targeting the H protein from its natural receptors 6 and the display of a CD20-specific single-chain antibody. 4 Receptor usage is a key determinant of MV tropism and of viral attenuation. [7] [8] [9] Vaccine strains use CD46 as receptor, a complement regulatory molecule that is ubiquitously expressed on all nucleated human cells. Wild-type (WT) isolates causing disease are usually unable to enter cells through CD46. Their lymphatic cell receptor is the signaling lymphocyte activation molecule (SLAM or CD150). 8 SLAM, which can also be used by vaccine strains, is a type I transmembrane protein of the immunoglobulin superfamily. It is expressed on immature thymocytes, memory T cells, B cells, macrophages and mature dendritic cells. Stimulation with antigens or mitogens upregulates SLAM expression. 10 An unidentified receptor (EpR) is used by MV in late stages of infection, when MV infects airway epithelial cells and sheds from the respiratory system. 7, 11, 12 We hypothesized that lentiviral vectors pseudotyped with the envelope proteins of WT MV will exhibit the tropism of clinical MV isolates, that is use SLAM and EpR for cell entry. The data show that MV WT -HIV vectors exhibit a restricted tropism for activated lymphocytes and epithelial cells and can be generated at substantially higher titers than MV Vac -HIV vectors.
Results and discussion
We used the F and H proteins of the WT MV strain IC-B, recombinant clone IC323, 13 cloned in expression plasmids (pCG-IC323-H, pCG-IC323-F). 7 Alignment of these proteins with the F and H proteins of the NSe variant of the MV vaccine strain Edmonston B 14 revealed no amino acid exchanges in F, and 17 amino acid exchanges in H, respectively. All amino acid exchanges in H localized to the extracellular domain, and the amino-acid sequence of the cytoplasmic tail was completely conserved. To achieve pseudotyping, we truncated the cytoplasmic tails as performed earlier for the MV Vac glycoproteins, that is by 18 amino acids for the H protein and 30 amino acids for the F protein. 4 The pCG-H WT D18 plasmid was constructed by subcloning a PCR fragment generated with the primers Hwt(+)D18 5 0 -CCTTAATTAAAACT  TAGGGTGCAAGATCATCCACAATGGGAAGTAGGA  TAGTTATTAACAGAG-3 0 , Hwt(-)D18 5 0 -GGCCTCCAG TAGAGTTGAGTTCACCAATGCATTC-3 0 and pCG-IC323-H as template into the PacI/NsiI-digested pCG-IC323-H plasmid. The plasmid pCG-F WT D30 was generated after PCR amplification based on primers Fwt-Stop(+) 5 0 -GCTGCAGGGGGCGCTGAAACAAAAA GGGAG-3 0 and Fwt-Stop(-) 5 0 -CTCCCTTTTTGTTTCA GCGCCCCCTGCAGC-3 0 and pCG-IC323-F as template. Vector particles were then generated by transient transfection of HEK-293T cells with the packaging plasmid pCMVDR8.9, the transfer vector plasmid pSEW and the envelope expression plasmids pCG-H WT D18 and pCG-F WT D30 (relative ratio of 3:5). 4 The vector particles were subsequently concentrated by low-speed centrifugation 4 with recovery rates of about 20%. In parallel, vector particles were also generated in the presence of the unmodified H WT and F WT proteins. Interestingly, and in contrast to the H Vac and F Vac proteins, the unmodified H WT and F WT proteins were readily detectable in vector particles (Figure 1a) . However, truncation of their cytoplasmic tails significantly enhanced particle incorporation, especially for the F WT protein. The incorporation of the H WT D18 protein was further verified by immune electron microscopy. HIV-1 particles with the expected size of about 100 nm and the typical lentiviral core structure were observed. They were decorated by gold particles showing the incorporation of the H WT D18 protein ( Figure 1b) .
Next, we determined the infectivity of particles on SLAM + Raji cells as described earlier. 4 After titration of five different stocks of MV WT -HIV vector particles, an average titer of 1.1 Â 10 8 t.u. ml À1 was determined (Table 1 ). When we incubated Raji cells with high amounts of MV WT -HIV vector particles (multiplicity of infection (MOI) of 100), we observed the formation of Raji cell syncytia, an indication for cell-cell fusion 'from without' mediated by a large number of vector particles bound to the cell surfaces (data not shown). 17 This high titer is remarkable in being significantly above any titer we had observed with MV Vac -HIV vector particles and is The blotted proteins were analyzed using anti-F, anti-H and anti-p24 antibodies as described earlier. 4 Signals were developed using the Amersham ECL Plus Western Blotting detection reagent (GE Healthcare, Munich, Germany). Cell supernatant from HEK-293T cells transfected with pUC18 instead of the glycoproteinencoding plasmids was loaded as negative control (nc). (b) Electron microscopy of concentrated HIV vector particles pseudotyped with H WT D18/F WT D30 proteins. Concentrated MV WT -HIV particles were adsorbed to glow discharged carbon-coated formvar grids for 10 min and then incubated for 20 min with an anti-MV H monoclonal antibody derived from the hybridoma cell line K83. 15 After washing with phosphate-buffered saline (PBS), the grids were incubated with a 1:100 dilution of a 10 nm gold labeled anti-mouse IgG (BioCell, Cardiff, UK) for 20 min, washed with PBS and finally stained with 2% phosphotungstate for 10 s. ). Vector particles produced in the presence of the unmodified F WT and H WT proteins exhibited about 100-fold lower titers. Truncating only one of the two glycoproteins enhanced titers about 10-fold ( Figure 1c ). As truncation of the H WT cytoplasmic tail had a minimal effect on particle incorporation, this modification may be required to enhance fusion-helper activity. 18 Next, we compared the tropism of MV WT -HIV with that of MV Vac -HIV vector particles using adherent and suspension cell lines. 4, 19, 20 MV WT -HIV particles transduced only SLAM-positive CHO cells, whereas MV Vac -HIV particles also transduced CHO-CD46 cells. The parental CHO-K1 cells, which express neither receptor, remained untransduced with both vector types ( Figure 2a , Table 1 ). Cells naturally expressing one or two of the MV receptors were also incubated with the MV WT -HIV or MV Vac -HIV particles, respectively (Table 1) . Raji cells, which express SLAM and CD46, were transduced by both particle types, whereas HT1080 cells expressing CD46 were selectively transduced by MV Vac -HIV particles. It is noteworthy that on all cell types tested, MV WT -HIV vectors were more infectious than MV Vac -HIV particles. Interestingly, this was also the case on the human bronchioalveolar carcinoma cell line NCI-H358 (ATCC CRL-5807), previously shown to express beside CD46 the EpR (Table 1) . 7, 11 Thus, the EpR must be at least as efficient as CD46 in mediating F/H-dependent cell entry.
To ) transduced both cell lines at a similar efficiency (Figure 2c, right panel) .
Next, we analyzed the transduction of primary human cells positive for EpR or SLAM. Human small airway epithelial cells (Lonza Verviers S.p.r.l., Belgium), which are permissive for infection by MV WT in the absence of SLAM, 7, 11, 21 were transduced by MV WT -HIV particles with at least the same efficiency as VSV-G-HIV particles (6.7 vs 3.4%, respectively; Figure 3a) . These results were confirmed with small airway epithelial cells from a second donor (data not shown). To further show that cell entry of the MV WT -HIV particles was SLAM-independent, we generated vector particles with the 194A mutant of the H WT protein, which interferes with SLAM binding. 22 These particles transduced small airway epithelial cells with high efficiency (11% GFP + cells) but were unable to transduce Raji cells (data not shown).
In an attempt to enhance SLAM expression and thereby transduction, primary human peripheral blood mononuclear cells were activated for 24 h by incubation in 2 ng ml
À1
Phorbol-12-myristate-13-acetate (Calbiochem, Darmstadt, Germany) and 1 mg ml À1 ionomycin (Sigma-Aldrich, Taufkirchen, Germany) containing medium (RPMI 1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine, 0.5% streptomycin/penicillin, 25 mM HEPES) resulting also in enrichment of T cells. Upon activation, SLAM expression in the T-cell-enriched fraction reached about 70% as determined by FACS analysis using the PE-conjugated mouse anti-human CD150 (SLAM) antibody (BioLegend, San Diego, CA, USA) (data not shown). After transduction with MV WT -HIV and VSV-G-HIV vectors, there was a decline in SLAM expression levels from about 70 to 50%, as compared with 1% positive cells in the isotype control sample (Figure 3b and data not shown). There were roughly similar numbers of GFP + cells for both vector types. However, their distribution among the SLAM Figure 3c ). In contrast, VSV-G-HIV particles mainly transduced the feeder cells (75%), whereas B-cell transduction was very inefficient (8%) (Figure 3c ).
In summary, we have shown that lentiviral vectors pseudotyped with the F and H proteins of WT MV are more selective and can be produced to higher titers than vectors pseudotyped with the vaccine strain glycoproteins. 4 ,5 MV WT -HIV vectors transduce cells through SLAM and EpR, but in contrast to MV Vac -HIV vectors they do not use the ubiquitously expressed CD46 for cell entry. It is remarkable that they were more efficient in transducing primary human cells, especially B cells, than VSV-G pseudotyped vectors. Moreover, they were more selective and transduced exclusively SLAM + cells in mixed cultures.
Remarkably, MV WT -HIV vector particles can be generated at 4-10-fold higher titers than MV Vac -HIV vector particles. This was not due to enhanced particle release from the transiently transfected packaging cells, as the p24 content of MV Vac -HIV stocks was on average twofold higher than that of MV WT -HIV stocks (data not shown). However, MV Vac -HIV packaging cells form extensive syncytia, whereas these are absent in packaging cells expressing the WT glycoproteins. It is likely that syncytia formation results in the enhanced release of p24 associated with cell debris and vesicles, which are noninfectious and thus reduce the infectivity/particle ratio of MV Vac -HIV vectors. showed that untargeted MV Vac -HIV vectors transduced quiescent T cells: both cell populations usually resistant against transduction by lentiviral vectors. As higher titers can be generated with MV WT -HIV vectors than with MV Vac -HIV vectors, it will be informative to see whether SLAM contact will be sufficient to allow transduction of quiescent T cells, and whether MV WT -HIV vectors will thus further improve the efficiency of T-cell-based gene transfer with lentiviral vectors. In addition, they may be used to deliver genes to certain cells of the airway epithelial system. As the H residues contacting SLAM are different from those contacting EpR, 7, 22 EpR-specific vectors that are SLAMblind can be generated. As the EpR is expressed basolaterally, gene transfer to lung and other epithelia upon systemic application may become feasible with this vector. 7 We also note that the use of the WT H protein as a scaffold for antibody-mediated targeting may improve titers of the MV-HIV-based targeting system. 4 Finally, the pseudotypes described here can be exploited for studies on MV cell entry and receptor usage. Owing to their unique property to integrate genetic information into the target cell genome, many viral receptors have been identified using genetic screens based on lentiviral or retroviral vectors. 25 Accordingly, MV WT -HIV vectors may be applied to identify the EpR.
